LDLR and familial hypercholesterolemia: For instance, some pathogenic mutations (such as p.E32K and p.R469W) can cause conformational changes in PCSK9, thereby affecting its ability to degrade LDLR, a mechanism that is also closely related to the occurrence of familial hypercholesterolemia [21].